Appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation
BA Steinberg, JB Washam - Trends in Cardiovascular Medicine, 2017 - Elsevier
The development of nonvitamin K antagonist oral anticoagulants (NOACs) has been a major
advance in therapy for patients requiring oral anticoagulation, particularly for long-term …
advance in therapy for patients requiring oral anticoagulation, particularly for long-term …
Appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation.
BA Steinberg, JB Washam - Trends in Cardiovascular Medicine, 2017 - europepmc.org
The development of nonvitamin K antagonist oral anticoagulants (NOACs) has been a major
advance in therapy for patients requiring oral anticoagulation, particularly for long-term …
advance in therapy for patients requiring oral anticoagulation, particularly for long-term …
Appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation
BA Steinberg, JB Washam - Trends in cardiovascular …, 2017 - pubmed.ncbi.nlm.nih.gov
The development of nonvitamin K antagonist oral anticoagulants (NOACs) has been a major
advance in therapy for patients requiring oral anticoagulation, particularly for long-term …
advance in therapy for patients requiring oral anticoagulation, particularly for long-term …